New techniques and models for assessing ischemic heart disease risks

View or download the full article: 
PDF icon health-risk-analysis-2017-3-5.pdf
UDC: 
615.47: 616-072.7
DOI: 
10.21668/health.risk/2017.3.05.eng
Authors: 

I.N. Yakovina1, N.A. Bannova1, E.V. Kashtanova2, Ya.V. Polonskaia2, Yu.I. Ragino2

Organization: 

1 Novosibirsk State Technical University, 20 K. Marksa Avenue, Novosibirsk, 630073, Russian Federation
2 Scientific Research Institute for Therapy and Preventive Medicine, 175/1 Borisa Bogatkova Str., Novosibirsk, 630089, Russian Federation

Abstract: 

The paper focuses on tasks of creating and implementing a new technique aimed at assessing ischemic heart diseases risk. The techniques is based on a laboratory-diagnostic complex which includes oxidative, lipid-lipoprotein, inflammatory and metabolic biochemical parameters; s system of logic-mathematic models used for obtaining numeric risk assessments; and a program module which allows to calculate and analyze the results. we justified our models in the course of our re-search which included 172 patients suffering from ischemic heart diseases (IHD) combined with coronary atherosclerosis verified by coronary arteriography and 167 patients who didn't have ischemic heart diseases. Our research program in-cluded demographic and social data, questioning on tobacco and alcohol addiction, questioning about dietary habits, chronic diseases case history and medications intake, cardiologic questioning as per Rose, anthropometry, 3-times meas-ured blood pressure, spirometry, and electrocardiogram taking and recording with decoding as per Minnesota code. We detected biochemical parameters of each patient and adjusted our task of creating techniques and models for assessing ischemic heart disease risks on the basis of inflammatory, oxidative, and lipid biological markers. We created a system of logic and mathematic models which is a universal scheme for laboratory parameters processing allowing for dissimilar data specificity. The system of models is universal, but a diagnostic approach to applied biochemical parameters is spe-cific. The created program module (calculator) helps a physician to obtain a result on the basis of laboratory research data; the result characterizes numeric risks of coronary atherosclerosis and ischemic heart disease for a patient. It also allows to obtain a visual image of a system of parameters and their deviation from a conditional «standard – pathology» boundary. The complex is implemented into practice by the Scientific Research Institute for Therapy and Preventive Medicine.

Keywords: 
risk assessment, ischemic heart disease, laboratory and diagnostic complex, biochemical parameters, logic and mathematic model, program module, questioning as per Rose
Yakovina I.N., Bannova N.A., Kashtanova E.V., Polonskaia Ya.V., Ragino Yu.I. New techniques and models for assessing ischemic heart disease risks. Health Risk Analysis, 2017, no. 3, pp. 40–47. DOI: 10.21668/health.risk/2017.3.05.eng
References: 
  1. Bokeriya L.A., Gudkova R.G. Bolezni sistemy krovoobrashcheniya i serdechno-sosudistaya khirurgiya v Rossiiskoi Federatsii. Sostoyanie i problemy [Cardiovascular system disease and cardiovascular surgery in the Russian Federation. Current situation and challenges]. Analiticheskii vestnik, 2015, vol. 597, no. 44, pp. 9–18 (in Russian).
  2. Polonskaya Ya.V., Kashtanova E.V., Murashev I.S., Kurguzov A.V., Volkov A.M., Kamenskaya O.V., Chernyavskii A.M., Ragino Yu.I. Vzaimosvyaz' osnovnykh pokazatelei kal'tsievogo i lipidnogo obmena s aterosklerozom koronarnykh arterii [The interrelation of the basic parameters of calcium and lipid metabolism with atherosclerosis of the coronary arteries]. Ateroskleroz i dislipidemii, 2015, vol. 18, no. 1, pp. 24–29 (in Russian).
  3. Ragino Yu.I., Kuimov A.D., Polonskaya Ya.V., Kashtanova E.V., Lozhkina N.G., Balabushevich T.A., Eremenko N.V., Negmadzhonov U.N. Dinamika izmenenii vospalitel'no-okislitel'nykh biomarkerov v krovi pri ostrom koronarnom sindrome [Dynamics of Changes of Blood Inflammatory-Oxidative Biomarkers in Acute Coronary Syndrome]. Kardiologiya, 2012, vol. 52, no. 2, pp. 18–23 (in Russian).
  4. Kardiologiya. Natsional'noe rukovodstvo. Kratkoe izdanie [Cardiology. National guidelines. Brief edition]. In: Yu.N. Belenkova, R.G. Organova, eds. Moscow, GEOTAR-Media Publ., 2012, 838 p. (in Russian).
  5. Boitsov S.A., Shal'nova S.A., Deev A.D., Kalinina A.M. Modelirovanie riska razvitiya serdechno-sosudistykh zabolevanii i ikh oslozhnenii na individual'nom i gruppovom urovnyakh [Simulation of a risk for cardiovascular diseases and their events at individual and group levels]. Terapevticheskii arkhiv, 2013, no. 9, pp. 4–10 (in Russian).
  6. Razvitie zdravookhraneniya NSO na 2013–2020 gody: Otchety o realizatsii gosudarstvennoi programmy [Public Healthcare development in Novosibirsk region for 2013–2020: report on the implementation of the state program]. Available at: http://www.zdrav.nso.ru/page/2372 (20.06.2017) (in Russian).
  7. Berger J.S., Jordan C.O., Lloyd-Jones D., Blumenthal R.S. Skrining serdechno-sosudistogo riska u bessimptomnykh patsientov [Cardiovascular risk screening for patients without symptoms]. Ratsional'naya farmakoterapiya v kardiologii, 2010, vol. 6, no. 3, pp. 381–390 (in Russian).
  8. Kharchenko V.I., Kakorina E.P., Koryakin M.V., Virin M.M., Undritsov V.M., Smirnova N.L., Onishchenko P.I., Potievskii B.G., Mikhailova R.Yu. Smertnost' ot boleznei sistemy krovoobrashcheniya v Rossii i v ekonomicheski razvitykh stranakh. Neobkhodimost' usileniya kardiologicheskoi sluzhby i modernizatsiya meditsinskoi statistiki v Rossiiskoi Federatsii (Analiticheskii obzor ofitsial'nykh dannykh Goskomstata, MZ i SR Rossii, VOZ i ekspertnykh otsenok po probleme) [Cardiovascular disease mortality in russia and developed countries: need for strengthening cardiology service and modernizing medical statistics in the Russian Federation (analytical review of official data from the state statistical committee, ministry of health of the russian federation, World Health Organization, and expert analyses)]. Rossiiskii kardiologicheskii zhurnal, 2005, no. 2, pp. 5–7 (in Russian).
  9. Didigova R.T., Inarokova A.M., Imagozheva M.Ya., Mamedov M.N. Sovremennye vzglyady na etiologiyu i diagnostiku ishemicheskoi bolezni serdtsa [Current Opinions About Etiology and Diagnosis of Coronary Heart Disease]. Lechebnoe delo, 2011, no. 4, pp. 11–17 (in Russian).
  10. Pozdnyakov Yu.M., Martsevich S.Yu., Koltunov I.E., Urinskii A.M. Stabil'naya stenokardiya [Stable pectoris]. Kardiologiya: natsional'noe rukovodstvo. In: Yu.N. Belenkova, R.G. Organova, eds. Moscow, GEOTAR-Media Publ., 2007, pp. 636–664 (in Russian).
  11. Chazov E.I. Puti snizheniya smertnosti ot serdechno-sosudistykh zabolevanii [How to reduce mortality from cardiovascular diseases]. Terapevticheskii arkhiv, 2008, no. 8, pp. 11–16 (in Russian).
  12. Shvaikova I.N., Stashevskii P.S. Algoritmy formirovaniya diagnosticheskikh reshenii [Algorithms for diagnostic solutions creation APEP-2010]. Aktual'nye problemy elektronnogo priborostroeniya APEP-2010: materialy VIII Mezhdunarodnoi konferentsii, Novosibirsk, 2010, vol. 5, pp. 122–127 (in Russian).
  13. Mureddu G.F., Drandimarte F., Faggiano P. [et al.]. Between risk charts and imaging: how should we stratify cardiovascular risk in clinical practice? Eur. Heart. J. Cardiovasc. Imaging., 2013, vol. 14, no. 5, pp. 401–416.
  14. Conroy R.M., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., De Bacquer D., Duci¬me-tière P., Jousilahti P., Keil U., Njølstad I., Oganov R.G., Thomsen T., Tunstall-Pedoe H., Tverdal A., Wedel H., Whincup P., Wilhelmsen L., Graham I.M.. Estimation of tem-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart. J., 2003, vol. 24, no. 11, pp. 987–1003.
  15. Graham I. [et al.]. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. J. Cardiovasc. Prev. Rehabil., 2007, no. 2, pp. 1–113.
  16. Ge Y., Wang T.J. Identifying novel biomarkers for cardiovascular disease risk prediction. J. Intern. Med., 2012, vol. 272, no. 5, pp. 430–439.
  17. Ragino Yu., Kashtanova E., Chernjavski A., Polonskaia Ya., Voevoda M. Relationship of osteonectin level with inflammatory, oxidative and lipid biomarkers in blood in coronary atherosclerosis and its complication. Abstr. XIII HUPO World Congress, Madrid, 2014, pp. 207.
  18. Zannad F., De Backer G., Graham I. [et al.]. Risk stratification in cardiovascular disease primary prevention – scoring systems, novel markers, and imaging techniques. Fundam. Clin. Pharmacol., 2012, vol. 26, no. 2, pp. 163–174.
Received: 
26.06.2017
Accepted: 
16.08.2017
Published: 
30.09.2017

You are here

Home